S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands

Motus GI (MOTS) Competitors

$0.68
-0.01 (-1.45%)
(As of 02/29/2024 ET)

MOTS vs. SINT, NVIV, BJDX, DMK, RNAZ, SPRC, AVTX, KTRA, SNES, and PBLA

Should you be buying Motus GI stock or one of its competitors? The main competitors of Motus GI include Sintx Technologies (SINT), InVivo Therapeutics (NVIV), Bluejay Diagnostics (BJDX), DMK Pharmaceuticals (DMK), TransCode Therapeutics (RNAZ), SciSparc (SPRC), Avalo Therapeutics (AVTX), Kintara Therapeutics (KTRA), SenesTech (SNES), and Panbela Therapeutics (PBLA). These companies are all part of the "medical" sector.

Motus GI vs.

Motus GI (NASDAQ:MOTS) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation, profitability and community ranking.

Motus GI has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500.

Motus GI currently has a consensus target price of $28.88, indicating a potential upside of 4,146.32%. Given Motus GI's stronger consensus rating and higher probable upside, equities research analysts plainly believe Motus GI is more favorable than Sintx Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Motus GI
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Sintx Technologies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Sintx Technologies has higher revenue and earnings than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$590K0.80-$18.60M-$35.91-0.02
Sintx Technologies$1.56M0.47-$12.04MN/AN/A

Motus GI received 127 more outperform votes than Sintx Technologies when rated by MarketBeat users. Likewise, 65.73% of users gave Motus GI an outperform vote while only 61.02% of users gave Sintx Technologies an outperform vote.

CompanyUnderperformOutperform
Motus GIOutperform Votes
163
65.73%
Underperform Votes
85
34.27%
Sintx TechnologiesOutperform Votes
36
61.02%
Underperform Votes
23
38.98%

Sintx Technologies has a net margin of -397.27% compared to Motus GI's net margin of -3,776.10%. Sintx Technologies' return on equity of -85.77% beat Motus GI's return on equity.

Company Net Margins Return on Equity Return on Assets
Motus GI-3,776.10% -3,413.36% -96.95%
Sintx Technologies -397.27%-85.77%-54.20%

8.6% of Motus GI shares are held by institutional investors. Comparatively, 2.7% of Sintx Technologies shares are held by institutional investors. 1.6% of Motus GI shares are held by insiders. Comparatively, 1.0% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Motus GI had 2 more articles in the media than Sintx Technologies. MarketBeat recorded 6 mentions for Motus GI and 4 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.86 beat Motus GI's score of 0.53 indicating that Sintx Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Motus GI
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sintx Technologies
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Motus GI beats Sintx Technologies on 9 of the 16 factors compared between the two stocks.


Get Motus GI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MOTS vs. The Competition

MetricMotus GISurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$470,000.00$3.80B$4.96B$7.50B
Dividend YieldN/A2.06%2.88%3.87%
P/E Ratio-0.0212.04196.6214.91
Price / Sales0.8026.063,036.89173.41
Price / CashN/A25.6496.2355.17
Price / Book0.074.014.464.66
Net Income-$18.60M$20.20M$114.21M$211.48M
7 Day Performance-13.93%1.99%4.26%2.63%
1 Month Performance5.70%2.05%8.76%5.46%
1 Year Performance-94.85%2.24%12.18%8.67%

Motus GI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SINT
Sintx Technologies
0 of 5 stars
$0.15
flat
N/A-95.1%$786,000.00$1.56M0.0041Gap Up
NVIV
InVivo Therapeutics
0 of 5 stars
N/AN/AN/A$997,000.00N/A0.006Analyst Report
Gap Down
BJDX
Bluejay Diagnostics
2.4292 of 5 stars
$0.81
+2.5%
N/A-94.2%$1.00M$250,000.00-0.0816Short Interest ↓
Gap Down
DMK
DMK Pharmaceuticals
0 of 5 stars
$0.04
flat
$1.50
+3,404.7%
N/A$432,000.00$3.62M0.0011Gap Down
RNAZ
TransCode Therapeutics
3.5038 of 5 stars
$0.68
flat
$480.00
+70,592.2%
-99.8%$428,000.00N/A0.0019Short Interest ↓
SPRC
SciSparc
0 of 5 stars
$4.02
+15.5%
N/A-80.7%$482,000.00$3.32M0.003Short Interest ↓
News Coverage
Gap Up
High Trading Volume
AVTX
Avalo Therapeutics
0.4563 of 5 stars
$4.20
-5.8%
N/A-99.3%$357,000.00$2.25M-0.0120Short Interest ↓
KTRA
Kintara Therapeutics
0.3358 of 5 stars
$0.10
flat
N/A-97.9%$332,000.00N/A-0.022Short Interest ↑
Gap Up
High Trading Volume
SNES
SenesTech
2.1502 of 5 stars
$1.06
-2.8%
$3.50
+230.2%
-96.4%$318,000.00$1.02M0.0029Short Interest ↑
PBLA
Panbela Therapeutics
2.6538 of 5 stars
$1.18
-5.6%
$500.00
+42,272.9%
-99.9%$307,000.00N/A0.006Short Interest ↓

Related Companies and Tools

This page (NASDAQ:MOTS) was last updated on 3/1/2024 by MarketBeat.com Staff